Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins

BioEssays

Volumn 20, Issue 2, 1998, Pages 156-167

  Hileman, Ronald E ^a   Fromm, Jonathan R ^a   Weiler, John M ^a,c   Linhardt, Robert J ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b Department of Internal Medicine ^*  (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; GLYCOSAMINOGLYCAN; PROTEIN;

AMINO ACID SEQUENCE; BINDING SITE; CARBOHYDRATE ANALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; CONSENSUS SEQUENCE; GENETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; PROTEIN SECONDARY STRUCTURE; REVIEW; THERMODYNAMICS;

AMINO ACID SEQUENCE; AMINO ACIDS; BINDING SITES; CARBOHYDRATE SEQUENCE; CONSENSUS SEQUENCE; GLYCOSAMINOGLYCANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEINS; THERMODYNAMICS;

EID: 0032006909     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.0.CO;2-R     Document Type: Review

References (64)

1. Lane, D. A. and Lindahl, U. (1989) Heparin, Chemical and Biological Properties, Clinical Applications. CRC Press, Inc., Boca Raton, FL.
2. Jacobsson, K. G. and Lindahl, U. (1987) Degradation of heparin proteoglycan in cultured mouse mastocytoma cells. Biochem J 246:409-415.
3. Gallagher, J. T., Turnbull, J. E. and Lyon, M. (1992) Heparan sulphate proteoglycans: Molecular organization of membrane-associated species and an approach to polysaccharide sequence. Adv Exp Med Biol 313:49-57.
4. Bernfield, M., Kokenyesi, R., Kato, M., Hinkes, M. T., Spring, J., Gallo, B. L. and Lose, E. J. (1992) Biology of the syndecans [review]. Ann Rev Cell Biol. 8:365-393.
5. Casu, B. (1985) Structure and biological activity of heparin. Adv Carbohydr Chem Biochem 43:51-134.
6. Linhardt, R. J., Ampofo, S. A., Fareed, J., Hoppensteadt, D., Mulliken, J. B. and Folkman, J. (1992) Isolation and characterization of human heparin. Biochemistry 31:12441-12445.
7. Griffin, C. C., Linhardt, R. J., Van Gorp, C. L., Toida, T., Hileman, R. E., Schubert, R. L. and Brown, S. E. (1995) Isolation and characterization of heparan sulfate from crude porcine intestinal mucosal peptidoglycan heparin. Carbohydr Res 276:183-197.
8. Linhardt, R. J., Rice, K. G., Kim, Y. S., Engelken, J. and Weiler, J. M. (1988) Homogeneous, structurally defined heparin oligosaccharides with low anticoagulant activity inhibit the generation of the amplification pathway C3 convertase. J Biol Chem 263:13090-13096.
9. Templeton, D. M. (1992) Proteoglycans in cell regulation [review]. Crit Rev Clin Lab Sci 29:141-184.
10. Linhardt, R. J. and Toida, T. (1997) Heparin analogs-development and applications [review]. In Carbohydrates as Drugs (eds. Z. B. Witczak and K. A. Nieforth) Marcel Dekker, New York, Chapter 7, pp. 277-341.
11. Folkman, J. and Shing, Y. (1992) Control of angiogenesis by heparin and other sulfated polysacchandes [review]. Adv Exp Med Biol 313:355-364.
12. Riegel, A. T. and Wellstein, A. (1994) The potential role of the heparin-binding growth factor pleiotrophin in breast cancer [review]. Breast Ca Res Treatment 31:309-314.
13. Newman, S. A., Frenz, D. A., Hasegawa, E. and Akiyama, S. K. (1987) Matrix-derived translocation: Dependence on interaction of amino-terminal domain of fibronectin with heparin-like surface components of cells or particles. Proc Natl Acad Sci USA 84:4791-4795.
14. Harpel, P. C., Zhang, X. and Borth, W. (1996) Homocysteine and hemostasis pathogenic mechanisms predisposing to thrombosis [review]. J Nutrition 126(4 Suppl)1285S-1289S.
15. Suenaga, R. and Abdou, N. I. (1995) Heparan sulphate-ELISA gives false positive results for anti-DNA-DNA/histone immune complexes in sera of patients with SLE. Lupus 4:57-62.
16. van Putten, J. P. and Paul, S. M. (1995) Binding of syndecan-like cell surface proteoglycan receptors is required for Neisseria gonorrhoeae entry into human mucosal cells. EMBO J 14:2144-2154.
17. Kardami, E., Pearson, T. W., Beecroft, R. P. and Fandrich, R. R. (1992) Identification of basic fibroblast growth factor-like proteins in African trypanosomes and Leishmania. Mol Biochem Parasit 51:171-181.
18. Flynn, S. J. and Ryan, P. (1996) The receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant J Virology 70:1355-1364.
19. Chen, Y., Maguire, T., Hileman, R. E., Fromm, J. R., Esko, J. D., Linhardt, R. J. and Marks, R. M. (1997) Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nature Med 3:866-871.
20. Sawitzky, D. (1996) Protein-glycosaminoglycan interactions: infectiological aspects [review]. Med Microbiol Immunol 184:155-161.
21. Cardin, A. D. and Weintraub, H. J. R. (1989) Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 9:21-32.
22. Sobel, M., Soler, D. F., Kermode, J. C. and Harris, R. B. (1992) Localisation and characterization of a heparin binding domain peptide of human von Willebrand factor. J Biol Chem 267:8857-8862.
23. Margalit, H., Fischer, N. and Ben-Sasson, S. A. (1993) Compara live analysis of structurally defined heparin binding sequences reveals a distinct spatial distribution of basic residues. J Biol Chem 268:19228-19231.
24. Carrell, R. W., Christey, P. B. and Boswell, D. R. (1987) Haemostasis. In Thrombosis, (eds. M. Verstraete, J. Vermylen, H.R. Lijenen and J. Arnout), p 1-15. Leuven University Press, Leuven.
25. Petitou, M., Lormeau, J.-C. and Choay, J. (1988) Interaction of heparin and antithrombin III. The role of O-sulfate groups. Eur J Biochem 176:637-640.
26. Sinaÿ, P. (1987) Recent advances in the study of the binding site of heparin to antithrombin. Pure Appl Chem 59:445-448.
27. Sinaÿ, P., Jacquinet, J.-C., Petitou, M., Duchaussoy, P., Lederman, I., Choay, J. and Torri, G. (1984) Total synthesis of a heparin pentasaccharide fragment having high affinity for antithrombin III. Carbohydr Res 132:C5-C9.
28. Jackson, R. L., Busch, S. J. and Cardin, A. D. (1991) Glycosaminoglycans: Molecular properties, protein interactions, and role in physiological processes [review]. Physiol Rev 71:481-539.
29. Sheehan, J. P. and Sadler, J. E. (1994) Molecular mapping of the heparin-binding exosite of thrombin. Proc Natl Acad Sci USA 91: 5518-5522.
30. Godavarti, R., Cooney, C. L., Langer, R. and Sasisekharan, R. (1996) Heparinase I from Flavobacterium heparinum. Identification of a critical histidine residue essential for catalysis as probed by chemical modification and site-directed mutagenesis. Biochemistry 35:6846-6852.
31. Rosenfeld, L. and Danishefsky, I. (1986) A fragment of antithrombin that binds both heparin and thrombin. Biochem J 237:639-646.
32. Bae, J., Desai, U. R., Pervin, A., Caldwell, E. E. O., Weiler, J. M. and Linhardt, R. J. (1994) Interaction of heparin with synthetic antithrombin III peptide analogues. Biochem J 301:121-129.
33. Tollefsen, D. M., Maimone, M. M., McGuire, E. A. and Peacock, M. E. (1989) Heparin cofactor II activation by dermatan sulfate. Ann NY Acad Sci 556:116-122.
34. Linhardt, R. J. and Hileman, R. E. (1995) Dermatan sulfate as a potential therapeutic agent. Gen Pharmac 26:443-451.
35. Faham, S., Hileman, R. E., Fromm, J. R., Linhardt, R. J. and Rees, D. C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116-1120.
36. Walker, A., Turnbull, J. E. and Gallagher, J. T. (1994) Specific heparan sulfate saccharides mediate the activity of basic fibroblast growth factor. J Biol Chem 269:931-935.
37. Wang, H., Bernfield, M., Toida, T., Kim, Y. S., Capila, I., Hileman, R. E. and Linhardt, R. J. (1997) Glycosaminoglycans can influence fibroblast growth factor-2 mitogenicity without significant growth factor binding. Biochem Biophys Res Comm 235:369-373.
38. Ashikari, S., Habuchi, H. and Kimata, K. (1995) Characterization of heparin sulfate oligosaccharides that bind to hepatocyte growth factor. J Biol Chem 270:29586-29593.
39. Mulloy, B., Forster, M. J., Jones, C. and Davies, D. B. (1993) NMR and molecular modeling of the solution conformation of heparin. Biochem J 293:849-858.
40. Record, T. M., Lohman, T. M. and de Haseth, P. J. (1976) Ion effects on ligand-nucleic acid interactions. Mol Biol 107:145-158.
41. Manning, G. S. (1972) On the application of polyelectrolyte "limiting laws" to the helix-coil transition of DNA. I. Excess univalent cations. Biopolymers 11, 937-949.
42. Lohman, T. M. and Mascotti, D. P. (1992) Thermodynamics of ligand-nucleic acid interactions. Methods Enzymol 212:400-424.
43. Sicinsfca, W., Adams, B. and Lerner, L. (1993) A detailed 1H and 13C NMR study of a repeating disaccharide of hyaluronan: the effects of temperature and counterion type. Carbohydr Res 242:29-51.
44. Anderson, C. F., Record, M. T. and Hart, P. A. (1978) Sodium-23 NMR studies of cation-DNA interactions. Biophys Chem 7:301-316.
45. Manning, G. S. (1972) On the application of polyelectrolyte "limiting laws" to the helix-coil transition of DNA. I. Excess univalent cations. Biopolymers 11:937-949.
46. Olson, S. T., Halvorson, H. R. and Bjork, I. (1991) Quantitative characterization of the thrombin-heparin interaction. J Biol Chem 266:6342-6352.
47. Faller, B., Mely, Y., Gerard, D. and Bieth, J. G. (1992) Heparin-induced conformational change and activation of mucus proteinase inhibitor. Biochemistry 31:8285-8290.
48. Thompson, L. D., Pantoliano, M. W. and Springer, B. A. (1994) Energetic characterization of the basic fibroblast growth factor-heparin interaction: Identification of the heparin binding domain. Biochemistry 33:3831-3840.
49. Mascotti, D. P. and Lohman, T. M. (1995) Thermodynamics of charged oligopeptide-heparin interactions. Biochemistry 34:2908-2915.
50. Caldwell, E. E. O., Nadkarni, V. D., Fromm, J. R., Linhardt, R. J. and Weiler, J. M. (1996) Importance of specific amino acids in protein binding sites for heparin and heparan sulfate. Intl J Biochem Cell Biol 28:203-216.
51. Fromm, J. R., Hileman, R. E., Caldwell, E. E. O., Weiler, J. M. and Linhardt, R. J. (1995) Differences in the interaction of heparin with arginine and lysine and the importance of these basic amino acids in the binding of heparin to acidic fibroblast growth factor. Arch Biochem Biophys 323:279-287.
52. Fromm, J. R. (1996) The interaction of proteins with glycosaminoglycans: Studies on the interaction of acidic fibroblast growth factor with heparin and heparan sulfate. Dissertation University of Iowa, Iowa City, IA.
53. Fromm, J. R., Hileman, R. E., Caldwell, E. E. O., Weiler, J. M. and Linhardt, R. J. (1997) Pattern and spacing of basic amino acids in heparin binding sites. Arch Biochem Biophys 343:92-100.
54. Fromm, J. R., Hileman, R. E., Weiler, J. M. and Linhardt, R. J. (1997) Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides. Arch Biochem Biophys 346:252-262.
55. Volkin, D. B., Tsai, P. K., Dabora, J. M., Gress, J. O., Burke, C. J. and Linhardt, R. J. (1993) Physical stabilization of acidic fibroblast growth factor by polyanions. Arch Biochem Biophys 300:30-41.
56. Mach, H., Volkin, D. B., Burke, C. J., Middaugh, C. R., Linhardt, R. J., Fromm, J., Loganathan, D. and Mattsson, L. (1993) Nature of the interaction of heparin with acidic fibroblast growth factor. Biochemistry 32:5480-5489.
57. Edens, R. E., Fromm, J. R., Fromm, S. J., Linhardt, R. J. and Weiler, J. M. (1995) Two-dimension affinity resolution electrophoresis demonstrates that three distinct heparin populations interact with antithrombin III. Biochemistry 34:2400-2407.
58. Nelson, R. M., Venot, A., Bevilacqua, M. P., Linhardt, R. J. and Stamenkovic, I. (1995) Carbohydrate-protein interactions in vascular biology [review]. Ann Rev Cell Dev Biol 11:601-631.
59. Zhu, X., Hsu, B. T. and Rees, D. C. (1993) Structural studies of the binding of the anti-ulcer drug sucrose octasulfate to acidic fibroblast growth factor. Structure 1:27-34.
60. Chou, P. Y. and Fasman, G. D. (1978) Empirical predictions of protein conformation. Ann Rev Biochem 47:251-278.
61. Huntington, J. A., Olson, S. T., Fan, B. and Gettins, P. G. (1996) Mechanism of heparin activation of antithrombin. Evidence for reactive centerloop preinsertion with expulsion upon heparin binding. Biochemistry 35:8495-8503.
62. Mille, B., Watton, J., Barrowcliffe, T. W., Mani, J. C. and Lane, D. A. (1994) Role of N-and C-terminal amino acids in antithrombin binding to pentasaccharide. J Biol Chem 269:29435-29443.
63. van den Born, J., Gunnarsson, K., Bakker, M. A., Kjellen, L., Kusche-Gullberg, M., Maccarana, M., Berden, J. H. and Lindahl, U. (1995) Presence of N-unsubstituted glucosamine units in native heparan sulfate revealed by a monoclonal antibody. J Biol Chem 270:31303-31309.
64. Toida, T., Yoshida, H., Toyoda, H., Koshiishi, I., Imanari, T., Hileman, R. E., Fromm, J. R. and Linhardt, R. J. (1997) Structural differences and the presence of unsubstituted amino groups in heparan sulphates from different tissues and species. Biochem J 322:499-506.